Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 9, 2021
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
Tue, June 8, 2021
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
[ Tue, Jun 08th 2021
] - WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $455 on, Jun 8th, 2021
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $343 to $455 on, Jun 8th, 2021.
Matthew has made no other calls on BIIB in the last 4 months.
There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
- Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $268 on, Wednesday, February 17th, 2021
This is the rating of the analyst that currently disagrees with Matthew
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Tuesday, May 18th, 2021
